1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Veverka, V.
Bauerova, H.
Zabransky, A.
Lang, J.
Ruml, T.
Pichova, I.
Hrabal, R.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
J.MOL.BIOL.
JMOBAK
0070
0022-2836
333
771
780
10.1016/j.jmb.2003.08.049
14568536
Three-dimensional structure of a monomeric form of a retroviral protease
2003
10.2210/pdb1nso/pdb
pdb_00001nso
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
12189.059
Protease 13 kDa
3.4.23.-
C7A, C106A, D26N
1
man
polymer
no
no
WVQPITAQKPSLTLWLDDKMFTGLINTGADVTIIKLEDWPPNWPITDTLTNLRGIGQSNNPKQSSKYLTWRDKENNSGLI
KPFVIPNLPVNLWGRDLLSQMKIMMAS
WVQPITAQKPSLTLWLDDKMFTGLINTGADVTIIKLEDWPPNWPITDTLTNLRGIGQSNNPKQSSKYLTWRDKENNSGLI
KPFVIPNLPVNLWGRDLLSQMKIMMAS
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Betaretrovirus
Mason-Pfizer monkey virus
Escherichia
sample
1
107
pol
11942
Simian retrovirus SRV-1
562
Escherichia coli
PLASMID
Biological sequence
database_2
pdbx_nmr_software
pdbx_nmr_spectrometer
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
entity
entity_src_gen
struct_ref
struct_ref_seq
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
Database references
Source and taxonomy
Structure summary
1
0
2003-02-18
1
1
2008-04-29
1
2
2011-07-13
1
3
2021-10-27
1
4
2021-11-10
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
_pdbx_nmr_spectrometer.model
_struct_ref_seq_dif.details
_entity.pdbx_description
_entity_src_gen.pdbx_beg_seq_num
_entity_src_gen.pdbx_end_seq_num
_entity_src_gen.pdbx_gene_src_gene
_entity_src_gen.pdbx_gene_src_scientific_name
_entity_src_gen.pdbx_seq_type
_struct_ref.db_code
_struct_ref.pdbx_align_begin
_struct_ref.pdbx_db_accession
_struct_ref_seq.db_align_beg
_struct_ref_seq.db_align_end
_struct_ref_seq.pdbx_db_accession
_struct_ref_seq_dif.pdbx_seq_db_accession_code
_struct_ref_seq_dif.pdbx_seq_db_seq_num
RCSB
Y
RCSB
2003-01-28
REL
REL
The structure was determined using triple-resonance NMR spectroscopy.
structures with the least restraint violations
100
10
3D_13C-separated_NOESY
3D_15N-separated_NOESY
4D_13C/15N-separated_NOESY
50 mM
4.2
ambient
298
K
torsion angle dynamics
4
lowest energy
1mM Protease U-15N,13C; 50mM acetate buffer NA
95% H2O/5% D2O
Bruker
collection
XwinNMR
3.1
Delaglio, F.
processing
NMRPipe
2.1
Goddard, T.D., Kneller, D.G.
data analysis
Sparky
3.106
Linge, J., O'Donoghue, S., Nilges, M.
structure solution
ARIA
1.1
Linge, J., O'Donoghue, S., Nilges, M.
refinement
ARIA
1.1
500
Bruker
AVANCE
TRP
1
n
1
TRP
1
A
VAL
2
n
2
VAL
2
A
GLN
3
n
3
GLN
3
A
PRO
4
n
4
PRO
4
A
ILE
5
n
5
ILE
5
A
THR
6
n
6
THR
6
A
ALA
7
n
7
ALA
7
A
GLN
8
n
8
GLN
8
A
LYS
9
n
9
LYS
9
A
PRO
10
n
10
PRO
10
A
SER
11
n
11
SER
11
A
LEU
12
n
12
LEU
12
A
THR
13
n
13
THR
13
A
LEU
14
n
14
LEU
14
A
TRP
15
n
15
TRP
15
A
LEU
16
n
16
LEU
16
A
ASP
17
n
17
ASP
17
A
ASP
18
n
18
ASP
18
A
LYS
19
n
19
LYS
19
A
MET
20
n
20
MET
20
A
PHE
21
n
21
PHE
21
A
THR
22
n
22
THR
22
A
GLY
23
n
23
GLY
23
A
LEU
24
n
24
LEU
24
A
ILE
25
n
25
ILE
25
A
ASN
26
n
26
ASN
26
A
THR
27
n
27
THR
27
A
GLY
28
n
28
GLY
28
A
ALA
29
n
29
ALA
29
A
ASP
30
n
30
ASP
30
A
VAL
31
n
31
VAL
31
A
THR
32
n
32
THR
32
A
ILE
33
n
33
ILE
33
A
ILE
34
n
34
ILE
34
A
LYS
35
n
35
LYS
35
A
LEU
36
n
36
LEU
36
A
GLU
37
n
37
GLU
37
A
ASP
38
n
38
ASP
38
A
TRP
39
n
39
TRP
39
A
PRO
40
n
40
PRO
40
A
PRO
41
n
41
PRO
41
A
ASN
42
n
42
ASN
42
A
TRP
43
n
43
TRP
43
A
PRO
44
n
44
PRO
44
A
ILE
45
n
45
ILE
45
A
THR
46
n
46
THR
46
A
ASP
47
n
47
ASP
47
A
THR
48
n
48
THR
48
A
LEU
49
n
49
LEU
49
A
THR
50
n
50
THR
50
A
ASN
51
n
51
ASN
51
A
LEU
52
n
52
LEU
52
A
ARG
53
n
53
ARG
53
A
GLY
54
n
54
GLY
54
A
ILE
55
n
55
ILE
55
A
GLY
56
n
56
GLY
56
A
GLN
57
n
57
GLN
57
A
SER
58
n
58
SER
58
A
ASN
59
n
59
ASN
59
A
ASN
60
n
60
ASN
60
A
PRO
61
n
61
PRO
61
A
LYS
62
n
62
LYS
62
A
GLN
63
n
63
GLN
63
A
SER
64
n
64
SER
64
A
SER
65
n
65
SER
65
A
LYS
66
n
66
LYS
66
A
TYR
67
n
67
TYR
67
A
LEU
68
n
68
LEU
68
A
THR
69
n
69
THR
69
A
TRP
70
n
70
TRP
70
A
ARG
71
n
71
ARG
71
A
ASP
72
n
72
ASP
72
A
LYS
73
n
73
LYS
73
A
GLU
74
n
74
GLU
74
A
ASN
75
n
75
ASN
75
A
ASN
76
n
76
ASN
76
A
SER
77
n
77
SER
77
A
GLY
78
n
78
GLY
78
A
LEU
79
n
79
LEU
79
A
ILE
80
n
80
ILE
80
A
LYS
81
n
81
LYS
81
A
PRO
82
n
82
PRO
82
A
PHE
83
n
83
PHE
83
A
VAL
84
n
84
VAL
84
A
ILE
85
n
85
ILE
85
A
PRO
86
n
86
PRO
86
A
ASN
87
n
87
ASN
87
A
LEU
88
n
88
LEU
88
A
PRO
89
n
89
PRO
89
A
VAL
90
n
90
VAL
90
A
ASN
91
n
91
ASN
91
A
LEU
92
n
92
LEU
92
A
TRP
93
n
93
TRP
93
A
GLY
94
n
94
GLY
94
A
ARG
95
n
95
ARG
95
A
ASP
96
n
96
ASP
96
A
LEU
97
n
97
LEU
97
A
LEU
98
n
98
LEU
98
A
SER
99
n
99
SER
99
A
GLN
100
n
100
GLN
100
A
MET
101
n
101
MET
101
A
LYS
102
n
102
LYS
102
A
ILE
103
n
103
ILE
103
A
MET
104
n
104
MET
104
A
MET
105
n
105
MET
105
A
ALA
106
n
106
ALA
106
A
SER
107
n
107
SER
107
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
LYS
19
A
O
LYS
19
A
N
LEU
16
A
N
LEU
16
A
N
TRP
15
A
N
TRP
15
A
O
ARG
71
A
O
ARG
71
A
N
TRP
70
A
N
TRP
70
A
O
GLY
78
A
O
GLY
78
A
N
LEU
49
A
N
LEU
49
A
O
ASN
60
A
O
ASN
60
1
A
A
O
HA
ASP
LYS
47
62
1.37
1
A
A
O
CA
ASP
LYS
47
62
2.02
1
A
A
O
CB
ASP
LYS
47
62
2.18
3
A
A
O
HA
ASP
LYS
47
62
0.95
3
A
A
O
CA
ASP
LYS
47
62
1.87
5
A
A
O
H
ASP
ASN
72
75
1.59
6
A
A
HG3
HA
GLN
ILE
63
85
1.11
6
A
A
OE1
O
GLN
VAL
63
84
2.15
7
A
A
O
HA
ASP
LYS
47
62
1.09
7
A
A
O
CA
ASP
LYS
47
62
2.03
8
A
A
O
O
LEU
ASN
49
60
2.17
9
A
A
O
H
ARG
ILE
53
55
1.45
9
A
A
O
N
ARG
ILE
53
55
2.19
1
A
ALA
7
61.38
153.76
1
A
GLN
8
-66.90
90.31
1
A
ASP
17
67.06
-66.78
1
A
ASP
18
-173.52
34.96
1
A
GLN
57
-43.32
93.12
1
A
SER
64
-34.50
163.23
1
A
LYS
66
-33.97
111.77
1
A
LYS
73
-39.78
-27.30
1
A
ASN
75
75.39
45.04
1
A
ASN
76
174.64
140.68
1
A
SER
77
-168.73
-47.11
1
A
LEU
88
68.36
84.61
1
A
PRO
89
-77.25
29.61
1
A
ASN
91
40.61
90.33
1
A
LYS
102
179.04
49.75
1
A
MET
105
-65.40
72.97
2
A
ALA
7
60.68
-171.19
2
A
ASP
17
24.07
34.30
2
A
ASP
18
167.97
-47.80
2
A
ASP
30
-147.45
-36.70
2
A
LYS
35
-46.61
162.94
2
A
PRO
40
-53.50
107.85
2
A
THR
46
-65.99
-179.78
2
A
ASP
47
148.56
-58.73
2
A
GLN
57
-42.81
93.44
2
A
LYS
66
-18.79
119.77
2
A
LYS
73
-36.69
-30.20
2
A
ASN
76
177.88
144.32
2
A
SER
77
177.53
-45.64
2
A
PRO
86
-86.09
48.29
2
A
ASN
87
-144.99
13.67
2
A
LEU
88
66.17
78.53
2
A
PRO
89
-69.20
9.18
2
A
VAL
90
95.09
-8.01
2
A
ASN
91
54.71
86.53
2
A
LYS
102
-147.10
-29.79
2
A
ILE
103
-76.36
-87.41
2
A
MET
105
-62.29
81.61
3
A
ALA
7
61.74
-178.53
3
A
GLN
57
-41.41
94.20
3
A
SER
64
-27.67
154.77
3
A
LYS
66
-31.59
146.22
3
A
LYS
73
-35.50
-33.31
3
A
SER
77
-174.21
-68.06
3
A
PRO
86
-83.75
43.41
3
A
LEU
88
65.69
86.03
3
A
PRO
89
-77.87
27.13
3
A
MET
104
-63.81
-174.82
3
A
MET
105
-67.80
72.73
4
A
ALA
7
60.51
-162.08
4
A
PRO
10
-68.41
60.29
4
A
ASP
30
-156.28
12.56
4
A
LYS
35
-49.80
163.24
4
A
THR
46
-65.89
-179.83
4
A
ASP
47
173.40
-48.97
4
A
GLN
57
-47.37
95.91
4
A
ASN
60
-68.23
-179.90
4
A
LYS
66
-22.98
114.52
4
A
LYS
73
-38.57
-29.13
4
A
ASN
76
-175.45
145.34
4
A
SER
77
179.98
-43.33
4
A
PRO
86
-81.97
35.83
4
A
LEU
88
66.56
81.40
4
A
PRO
89
-77.97
22.23
4
A
ASN
91
44.67
90.50
4
A
LYS
102
-178.07
42.01
4
A
MET
105
-65.67
76.99
5
A
ALA
7
62.77
130.33
5
A
GLN
8
-67.26
90.19
5
A
ASP
17
63.85
-67.90
5
A
ASP
18
-179.52
41.65
5
A
LYS
19
-170.13
148.58
5
A
THR
27
-54.99
-9.98
5
A
LYS
35
-48.02
163.24
5
A
GLN
57
-47.79
90.40
5
A
SER
64
-27.02
164.19
5
A
LYS
66
-22.40
121.63
5
A
ASN
75
76.79
44.31
5
A
ASN
76
173.89
150.36
5
A
SER
77
-173.11
-61.83
5
A
LEU
88
66.49
79.50
5
A
PRO
89
-79.07
23.81
5
A
ASN
91
44.97
81.09
5
A
LYS
102
-169.77
39.29
5
A
MET
104
-52.08
175.55
6
A
ALA
7
62.68
-163.12
6
A
PRO
10
-70.92
48.80
6
A
ASP
18
78.10
41.17
6
A
ASP
30
-131.92
-43.56
6
A
PRO
40
-56.15
109.24
6
A
GLN
57
-44.28
92.49
6
A
PRO
61
-32.33
179.47
6
A
LYS
66
-12.23
111.73
6
A
ASN
75
70.14
44.52
6
A
ASN
76
-176.05
144.35
6
A
SER
77
176.94
-51.71
6
A
PRO
86
-83.09
43.60
6
A
LEU
88
68.18
81.25
6
A
PRO
89
-78.27
21.73
6
A
LYS
102
-177.66
34.96
6
A
MET
105
-62.30
97.22
7
A
PRO
4
-58.61
98.05
7
A
ALA
7
64.52
-175.40
7
A
PRO
10
-82.46
47.63
7
A
ASP
30
-132.40
-46.57
7
A
THR
32
-54.66
102.27
7
A
THR
48
-69.51
93.56
7
A
GLN
57
-46.34
95.93
7
A
SER
64
-103.42
-161.50
7
A
LYS
66
22.36
100.81
7
A
LYS
73
-38.40
-29.75
7
A
ASN
76
-176.60
136.40
7
A
SER
77
-178.08
-47.72
7
A
LEU
88
77.90
70.92
7
A
PRO
89
-72.47
25.32
7
A
LYS
102
-172.28
33.92
7
A
ILE
103
-107.50
-66.14
8
A
PRO
4
-52.91
90.13
8
A
ALA
7
61.25
169.27
8
A
GLN
8
-61.15
90.29
8
A
PRO
10
-84.73
48.43
8
A
ASP
17
64.01
-74.36
8
A
ASP
18
-168.10
37.95
8
A
ASP
30
-133.07
-44.98
8
A
ASP
47
174.46
-32.54
8
A
GLN
57
-56.19
104.44
8
A
LYS
66
-15.74
107.77
8
A
SER
77
-178.25
-75.21
8
A
PRO
86
-81.59
36.52
8
A
LEU
88
77.54
81.66
8
A
VAL
90
83.03
-3.03
8
A
ASN
91
58.45
77.47
8
A
LYS
102
-161.69
51.76
8
A
ILE
103
-133.15
-73.20
9
A
ALA
7
64.27
127.85
9
A
GLN
8
-53.20
99.54
9
A
PRO
10
-68.83
57.29
9
A
PHE
21
-179.02
143.23
9
A
ASP
30
-155.10
11.68
9
A
LYS
35
-46.64
163.08
9
A
ASP
47
159.80
-63.75
9
A
ILE
55
47.56
27.08
9
A
LYS
66
-30.01
137.75
9
A
LYS
73
-37.75
-27.63
9
A
SER
77
174.76
-83.53
9
A
PRO
86
-82.71
48.42
9
A
LEU
88
62.07
77.66
9
A
PRO
89
-74.38
22.86
9
A
ASN
91
47.37
84.06
9
A
LYS
102
-158.87
29.75
9
A
ILE
103
-101.22
-68.34
9
A
MET
105
-58.62
87.34
10
A
ALA
7
64.50
173.24
10
A
ASP
17
46.97
28.65
10
A
ASP
18
74.45
47.98
10
A
LYS
35
-45.59
162.11
10
A
THR
46
-65.95
-179.67
10
A
ASP
47
174.59
-16.37
10
A
GLN
57
-46.78
100.93
10
A
SER
64
-35.94
155.21
10
A
LYS
66
-31.51
130.72
10
A
LYS
73
-31.17
-33.99
10
A
SER
77
170.65
-74.27
10
A
ASN
87
-151.97
11.93
10
A
LEU
88
61.45
80.87
10
A
PRO
89
-76.38
21.18
10
A
VAL
90
76.37
-1.68
10
A
ASN
91
52.60
84.48
10
A
LYS
102
178.75
45.40
10
A
MET
105
-65.92
75.72
Folded monomer of protease from Mason-Pfizer monkey virus
1
N
N
A
LYS
35
A
LYS
35
HELX_P
A
TRP
39
A
TRP
39
5
1
5
A
GLY
94
A
GLY
94
HELX_P
A
ILE
103
A
ILE
103
1
2
10
HYDROLASE
M-PMV, PROTEASE, VIRUS MATURATION, FOLDED MONOMER, HYDROLASE
POL_SRV1
UNP
1
761
P04025
WVQPITCQKPSLTLWLDDKMFTGLIDTGADVTIIKLEDWPPNWPITDTLTNLRGIGQSNNPKQSSKYLTWRDKENNSGLI
KPFVIPNLPVNLWGRDLLSQMKIMMCS
761
867
1NSO
1
107
P04025
A
1
1
107
1
CYS
engineered mutation
ALA
7
1NSO
A
P04025
UNP
767
7
1
ASP
engineered mutation
ASN
26
1NSO
A
P04025
UNP
786
26
1
CYS
engineered mutation
ALA
106
1NSO
A
P04025
UNP
866
106
4
2
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
LYS
19
A
LYS
19
A
GLY
23
A
GLY
23
A
LEU
12
A
LEU
12
A
LEU
16
A
LEU
16
A
LEU
68
A
LEU
68
A
ASP
72
A
ASP
72
A
ASN
76
A
ASN
76
A
ILE
80
A
ILE
80
A
LEU
49
A
LEU
49
A
LEU
52
A
LEU
52
A
GLN
57
A
GLN
57
A
ASN
60
A
ASN
60